Drug metabolism, pharmacokinetics and bioanalysis / / special issue editors, Hye Suk Lee, Kwang-Hyeon Liu.

Drug metabolism/pharmacokinetics and drug interaction studies have been extensively carried out in order to secure the druggability and safety of new chemical entities throughout the development of new drugs. Recently, drug metabolism and transport by phase II drug metabolizing enzymes and drug tran...

Full description

Saved in:
Bibliographic Details
TeilnehmendeR:
Year of Publication:2019
Language:English
Physical Description:1 electronic resource (230 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 04560nam-a2201153z--4500
001 993543950004498
005 20240424230118.0
006 m o d
007 cr|mn|---annan
008 202102s2019 xx |||||o ||| 0|eng d
020 |a 3-03897-917-1 
035 |a (CKB)4920000000095019 
035 |a (oapen)https://directory.doabooks.org/handle/20.500.12854/45509 
035 |a (EXLCZ)994920000000095019 
041 0 |a eng 
050 0 0 |a RM301.55 
082 0 0 |a 615.1  |2 23 
245 1 0 |a Drug metabolism, pharmacokinetics and bioanalysis /  |c special issue editors, Hye Suk Lee, Kwang-Hyeon Liu. 
260 |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2019 
300 |a 1 electronic resource (230 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
520 |a Drug metabolism/pharmacokinetics and drug interaction studies have been extensively carried out in order to secure the druggability and safety of new chemical entities throughout the development of new drugs. Recently, drug metabolism and transport by phase II drug metabolizing enzymes and drug transporters, respectively, as well as phase I drug metabolizing enzymes, have been studied. A combination of biochemical advances in the function and regulation of drug metabolizing enzymes and automated analytical technologies are revolutionizing drug metabolism research. There are also potential drug–drug interactions with co-administered drugs due to inhibition and/or induction of drug metabolic enzymes and drug transporters. In addition, drug interaction studies have been actively performed to develop substrate cocktails that do not interfere with each other and a simultaneous analytical method of substrate drugs and their metabolites using a tandem mass spectrometer. This Special Issue has the aim of highlighting current progress in drug metabolism/pharmacokinetics, drug interactions, and bioanalysis. 
546 |a English 
540 |a Creative Commons NonCommercial-NoDerivs  |u https://creativecommons.org/licenses/https://mdpi.com/books/pdfview/book/1904 
588 |a Description based on online resource ; title from PDF title page (viewed on 03/24/2021) 
506 0 |f Unrestricted online access  |2 star 
653 |a human liver microsomes 
653 |a alcohol addiction 
653 |a UGT 
653 |a ultra-high-pressure liquid chromatography 
653 |a adalimumab 
653 |a procainamide 
653 |a LC-MS/MS 
653 |a DA-9805 
653 |a paeonol 
653 |a LC-QTOF-MS/MS 
653 |a YRA-1909 
653 |a chlorogenic acid 
653 |a immunoprecipitation 
653 |a Eurycoma longifolia 
653 |a CYP 
653 |a caffeic acid 
653 |a rat 
653 |a pharmaceutical excipient 
653 |a Korean red ginseng extract 
653 |a Stauntonia hexaphylla leaf extract 
653 |a bioanalysis 
653 |a HPLC-MS/MS 
653 |a B6 
653 |a eurycomanone 
653 |a bioavailability 
653 |a drying technology 
653 |a GB3 
653 |a diclofenac 
653 |a 129-Glatm1Kul/J 
653 |a aglycone 
653 |a caffeic acid O-glucuronides 
653 |a organic anion transporting polypeptide 
653 |a protein precipitation 
653 |a metabolic stability 
653 |a Fabry disease 
653 |a biopharmaceuticals 
653 |a imperatorin 
653 |a neochlorogenic acid 
653 |a gastric ulcer 
653 |a saikosaponin a 
653 |a hair 
653 |a anthraquinone 
653 |a acetyl tributyl citrate 
653 |a pharmacokinetics 
653 |a brain distribution 
653 |a mematine 
653 |a ethyl glucuronide 
653 |a pharmacokinetic 
653 |a loxoprofen 
653 |a liquid chromatography-quadrupole TOF MS 
653 |a glucuronidation 
653 |a esomeprazole 
653 |a metformin 
653 |a cytochrome P450 
653 |a glycoside 
653 |a AUDIT score 
653 |a protein stability 
653 |a efficacy 
653 |a LC-HR/MS 
653 |a cryptochlorogenic acid 
653 |a aceclofenac 
653 |a drug interaction 
653 |a liquid chromatography-tandem mass spectrometry 
653 |a Osthenol 
653 |a plasma 
653 |a N-acetylprocainamide 
653 |a diabetes 
650 0 |a Drugs  |x Metabolism. 
776 |z 3-03897-916-3 
700 1 |a Lee, Hye Suk  |c (Pharmacist),  |e editor. 
700 1 |a Liu, Kwang-Hyeon,  |e editor. 
906 |a BOOK 
ADM |b 2024-04-26 03:05:22 Europe/Vienna  |f system  |c marc21  |a 2019-11-10 04:18:40 Europe/Vienna  |g false 
AVE |i DOAB Directory of Open Access Books  |P DOAB Directory of Open Access Books  |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5337497540004498&Force_direct=true  |Z 5337497540004498  |b Available  |8 5337497540004498